Palliative Care Protocol for Adult Patients Hospitalized in Critical Care Units.
NCT ID: NCT06483958
Last Updated: 2024-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
248 participants
INTERVENTIONAL
2024-01-02
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Assessing symptom burden (dyspnea, pain and/or anxiety/agitation) until death or day 5 (whichever comes first)
Researchers will compare the impact of the palliative care protocol with standard care to see if it improves the quality of care.
Participants will:
1. Symptom management.
2. Respect for the autonomy of the patient and his/her family environment.
3. Respectful management of clinical information.
4. Provision of holistic care and support.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Palliative Care in the ICU
NCT03263143
Respiratory Care in Intensive Care Unit for Neuromuscular Patients
NCT02936908
Efficacy of the "Start to Move" Protocol on Functionality, Delirium and Acquired Weakness in ICU
NCT05053724
Strengths and Weaknesses of Physiotherapy in the Daily Work of an Intensive Care Unit
NCT06407076
Impact of an Early Palliative Approach
NCT02471976
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Pre-intervention (control): The practices of each ICU will be maintained, until the moment that according to randomization corresponds the beginning of the intervention, in each center.
Post-intervention: Palliative care protocol to improve the quality of care
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Palliative care protocol
palliative care protocol
1. Symptom management
2. Respect for patient and family autonomy.
3. Respectful management of clinical information.
4. Provision of holistic care and support.
Standard care
None intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
palliative care protocol
1. Symptom management
2. Respect for patient and family autonomy.
3. Respectful management of clinical information.
4. Provision of holistic care and support.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalization in critical care unit for more than 48 hrs.
* Medical indication of therapeutic effort limitation, defined as: a) Non-initiation or withdrawal of life support therapies: invasive mechanical ventilation, vasoactive drugs, cardiopulmonary resuscitation, renal replacement therapy.
Exclusion Criteria
* Absence of legal representative and/or caregiver.
* Brain dead patient.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Chile
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Verónica Rojas
Santiago, Me, Chile
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OAIC 1315/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.